Literature Evidence and Arrive Assessment on Neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models

α
Ana Carolina Duarte
Ana Carolina Duarte
σ
Ana Carolina Bombardi Duarte
Ana Carolina Bombardi Duarte
ρ
Maycon Giovani Santanai
Maycon Giovani Santanai
Ѡ
Gulhermedi Camilo Orfalii
Gulhermedi Camilo Orfalii
¥
Carlos Tadeu Parisi de Oliveira
Carlos Tadeu Parisi de Oliveira
§
Denise GonAalves Priolli
Denise GonAalves Priolli
α University Medical School

Send Message

To: Author

Literature Evidence and Arrive Assessment on Neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models

Article Fingerprint

ReserarchID

CACLZ

Literature Evidence and Arrive Assessment on Neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

This paper was based on a literature search of PubMed and Scielo databases using the keywords “Flavonoids, Neuroprotection, Quercetin, Rutin, Isoquercitrin, Alzheimer, Parkinson, Huntington” and combinations of all the words. We collected relevant publications, during the period of 2000 to 2016, emphasizing in vivo and in vitro studies with neurological assessment of flavonol’s potentials, as well as classifying studies according to evidence levels, in order to elucidate evidence-based literature and its application on clinical research. In addition, we highlight the importance of flavonols in modern research fields, indicating their neuroprotective potential and use thereof as preventive and therapeutic treatment of numerous neurodegenerative disease. Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, represent worldwide a major health problem with great financial impact. They are multifactorial diseases, hallmarked by similar pathogenesis that covers conditions such as oxidative stress, formation of free radicals, abnormal protein dynamics (degradation and aggregation), mitochondrial dysfunction, lipid peroxidation and cellular death or senescence. Flavonols are polyphenolic compounds, widely distributed in the plant kingdom and found in high concentrations in vegetables, fruits and teas. Their neuroprotective effects are mainly related to their antioxidant, anti-proliferative and antiinflammatory properties. It was this paper’s intention to contribute with an evidence analysis of recent studies approaching neuroprotective effects of flavonols and the potential to conduct human clinical studies.

References

94 Cites in Article
  1. J Appleton (2010). Evaluating the Bioavailability of Isoquercetin.
  2. Anju Dhiman,Arun Nanda,Sayeed Ahmad (2012). A quest for staunch effects of flavonoids: Utopian protection against hepatic ailments.
  3. Nathália Amado,Danilo Predes,Marcela Moreno,Igor Carvalho,Fábio Mendes,José Abreu (2014). Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies.
  4. S Aherne,O' Brien,N (2002). Dietary flavonols: chemistry, food content, and metabolism.
  5. Anu Hopia,Marina Heinonen (1999). Antioxidant activity of flavonol aglycones and their glycosides in methyl linoleate.
  6. Kelly Heim,Anthony Tagliaferro,Dennis Bobilya (2002). Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.
  7. Mindaugas Liaudanskas,Pranas Viškelis,Raimondas Raudonis,Darius Kviklys,Norbertas Uselis,Valdimaras Janulis (2014). Phenolic Composition and Antioxidant Activity of<i>Malus domestica</i>Leaves.
  8. Marianne Reinboth,Siegfried Wolffram,Getu Abraham,Fritz Ungemach,Rainer Cermak (2010). Oral bioavailability of quercetin from different quercetin glycosides in dogs.
  9. S Subash,M Essa,S Al-Adawi,M Memon,T Manivasagam,M Akbar (2014). Neuroprotective effects of berry fruits on neurodegenerative diseases.
  10. Lucio Costa,Jacqueline Garrick,Pamela Roquè,Claudia Pellacani (2016). Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More.
  11. Seyed Razavi,Saber Zahri,Gholamreza Zarrini,Hossein Nazemiyeh,Sariyeh Mohammadi (2009). Biological activity of quercetin-3-O-glucoside, a known plant flavonoid.
  12. Aline Boligon,Michele Sagrillo,Luiz Machado,Olmiro De Souza Filho,Michel Machado,Ivana Da Cruz,Margareth Athayde (2012). Protective Effects of Extracts and Flavonoids Isolated from Scutia buxifolia Reissek against Chromosome Damage in Human Lymphocytes Exposed to Hydrogen Peroxide.
  13. Khushwant Bhullar,Hpv Rupasinghe (2013). Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases.
  14. Zbynek Gazdik,Vojtech Reznicek,Vojtech Adam,Ondrej Zitka,Tunde Jurikova,Boris Krska,Jan Matuskovic,Jan Plsek,Jan Saloun,Ales Horna,Rene Kizek (2008). Use of Liquid Chromatography with Electrochemical Detection for the Determination of Antioxidants in Less Common Fruits.
  15. I Solanki,P Parihar,M Parihar (2015). Neurodegenerative diseases: From available treatments to prospective herbal therapy.
  16. K Zeng,X Wang,H Fu,G Liu (2011). Protective effects and mechanism of hyperin on CoCl2-induced PC12 cells.
  17. F Moosavi,R Hosseini,L Saso,O Firuzi (2015). Modulation of neurotrophic signaling pathways by polyphenols.
  18. Ashfaq Ahmad,Tahir Ali,Hyun Park,Haroon Badshah,Shafiq Rehman,Myeong Kim (2016). RETRACTED ARTICLE: Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice.
  19. Namki Cho,Ji Choi,Heejung Yang,Eun Jeong,Ki Lee,Young Kim,Sang Sung (2012). Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines.
  20. Natalie Kelsey,Heather Wilkins,Daniel Linseman (2010). Nutraceutical Antioxidants as Novel Neuroprotective Agents.
  21. Carina Peritore,Angela Ho,Bryan Yamamoto,Scott Schaus (2012). Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.
  22. Genevieve Bureau,Fanny Longpré,M-G Martinoli (2008). Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation.
  23. A Witte,L Kerti,D Margulies,A Flöel (2014). Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.
  24. Izet Masic,Milan Miokovic,Belma Muhamedagic (2008). Evidence Based Medicine - New Approaches and Challenges.
  25. Patricia Burns,Rod Rohrich,Kevin Chung (2011). The Levels of Evidence and Their Role in Evidence-Based Medicine.
  26. L Medeiros,Stein A (2002). Níveis de evidência e graus de recomendação da medicina baseada em evidências.
  27. H Van Der Worp,David Howells,Emily Sena,Michelle Porritt,Sarah Rewell,Victoria O'collins,Malcolm Macleod (2010). Can Animal Models of Disease Reliably Inform Human Studies?.
  28. P Pound,M Bracken (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research?.
  29. Necdet Sut (2015). Study Designs in Medicine.
  30. Daniel Cressey (2016). Surge in support for animal-research guidelines.
  31. Kaeko Murota,Sumie Shimizu,Hitomi Chujo,Jae-Hak Moon,Junji Terao (2000). Efficiency of Absorption and Metabolic Conversion of Quercetin and Its Glucosides in Human Intestinal Cell Line Caco-2.
  32. Diksha Kaushik,Kevin O’fallon,Priscilla Clarkson,C Patrick Dunne,Karen Conca,Bozena Michniak‐kohn (2012). Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans.
  33. Lynn Cialdella-Kam,David Nieman,Wei Sha,Mary Meaney,Amy Knab,R Shanely (2013). Dose–response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults.
  34. Icw Arts,Ala Sesink,M Faassen-Peters,Pch Hollman (2004). The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
  35. Peter Hollman,Ilja Arts (2000). Flavonols, flavones and flavanols - nature, occurrence and dietary burden.
  36. De Araújo,Memb,Moreira Franco,Y Alberto,T (2013). Enzymatic de-glycosylation of rutin improves its antioxidant and antiproliferative activities.
  37. Sang Jung,Beum Kim,Eun Lee,Neville Osborne (2010). Isoquercitrin is the most effective antioxidant in the plant Thuja orientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells).
  38. Saba Sheikh,Safia,Ejazul Haque,Snober Mir (2013). Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions.
  39. Bayani Uttara,Ajay Singh,Paolo Zamboni,R Mahajan (2009). Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options.
  40. Barry Halliwell,Joseph Rafter,Andrew Jenner (2005). Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?.
  41. Sara Martín,Elena González-Burgos,M Carretero,M Gómez-Serranillos (2011). Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes.
  42. M Moniruzzaman,M Asaduzzaman,Md. Hossain,Jyotirmoy Sarker,S Rahman,Mamunur Rashid,Md. Rahman (2015). In vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of Phyllanthus acidus.
  43. Aline Boligon,Romaiana Pereira,Andriéli Feltrin,Michel Machado,Vanessa Janovik,João Rocha,Margareth Athayde (2009). Antioxidant activities of flavonol derivatives from the leaves and stem bark of Scutia buxifolia Reiss.
  44. Agnes Boots,Marjolein Drent,Vincent De Boer,Aalt Bast,Guido Haenen (2011). Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis.
  45. M Chung,S Lee,Y Park,Il,J Lee,K Kwon (2016). Neuroprotective effects of phytosterols and flavonoids from Cirsium setidens and Aster scaber in human brain neuroblastoma SK-N-SH cells.
  46. Mehmet Kanter,Cuneyt Unsal,Cevat Aktas,Mustafa Erboga (2016). Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus.
  47. Karim Jiménez-Aliaga,Paloma Bermejo-Bescós,Juana Benedí,Sagrario Martín-Aragón (2011). Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells.
  48. Lisa Mcanulty,Lindsey Miller,Peter Hosick,Alan Utter,John Quindry,Steven Mcanulty (2013). Effect of resveratrol and quercetin supplementation on redox status and inflammation after exercise.
  49. Rajesh Arora,Raman Chawla,Ravinder Sagar,Jagdish Prasad,Surendar Singh,Raj Kumar,Ashok Sharma,Shikha Singh,Rakesh Sharma (2005). Evaluation of radioprotective activities of Rhodiola imbricata Edgew – A high altitude plant.
  50. F Senol,O Acikara,G Citoglu,I Orhan,S Dall' Acqua,F Ozgokce (2014). Prospective neurobiological effects of the aerial and root extracts and some pure compounds of randomly selected Scorzonera species.
  51. C Dufour,M Loonis (2007). Flavonoids and their oxidation products protect efficiently albumin-bound linoleic acid in a model of plasma oxidation.
  52. James Dower,Johanna Geleijnse,Lieke Gijsbers,Casper Schalkwijk,Daan Kromhout,Peter Hollman (2015). Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial ,.
  53. Russell Swerdlow (2007). Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?.
  54. Carmela Spagnuolo,Marianna Napolitano,Idolo Tedesco,Stefania Moccia,Alfonsina Milito,Gian Luigi Russo (2016). Neuroprotective Role of Natural Polyphenols.
  55. G Higgins,P Beart,Y Shin,M Chen,N Cheung,P Nagley (2010). Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury.
  56. Chris Parsons,Wojciech Danysz,Andrzej Dekundy,Irena Pulte (2013). Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease.
  57. Po-Chuen Chan,Qingsu Xia,Peter Fu (2007). <i>Ginkgo Biloba</i>Leave Extract: Biological, Medicinal, and Toxicological Effects.
  58. C Shi,L Zhao,B Zhu (2009). Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells.
  59. E Morris,A Chalkidou,A Hammers,J Peacock,J Summers,S Keevil (2016). Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
  60. M Ansari,H Abdul,G Joshi,W Opii,D Butterfield (2009). Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.
  61. S-M Choi,B Kim,Y-H Cho (2014). Effects of Flavonoid Compounds on beta-amyloid-peptideinduced Neuronal Death in Cultured Mouse Cortical Neurons.
  62. R Liu,T Zhang,D Zhou (2013). Quercetin protects against the Abeta(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.
  63. Y Li,S Zhou,J Li (2015). Quercetin protects human brain microvascular endothelial cells from fibrillar beta-amyloid1-40-induced toxicity.
  64. Miki Hayakawa,Masanori Itoh,Kazunori Ohta,Shimo Li,Masashi Ueda,Miao-Xing Wang,Emika Nishida,Saiful Islam,Chihiro Suzuki,Kaori Ohzawa,Masuko Kobori,Takashi Inuzuka,Toshiyuki Nakagawa (2015). Quercetin reduces eIF2α phosphorylation by GADD34 induction.
  65. Nazanin Mohebali,Seyed Shahzadeh Fazeli,Hossein Ghafoori,Zeinab Farahmand,Elham Mohammadkhani,Faezeh Vakhshiteh,Abdolreza Ghamarian,Mansoureh Farhangniya,Mohammad Sanati (2016). Effect of flavonoids rich extract of<i>Capparis spinosa</i>on inflammatory involved genes in amyloid-beta peptide injected rat model of Alzheimer's disease.
  66. A Sabogal-Guáqueta,J Muñoz-Manco,J Ramírez-Pineda,M Lamprea-Rodriguez,E Osorio,G Cardona-Gómez (2015). The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
  67. H Javed,M Khan,A Ahmad (2012). Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.
  68. Ji Choi,Jeong Lee,Dong Lee,Sunghun Cho,Young-Ho Yoon,Eun Cho,Sanghyun Lee (2015). The <i>n</i> -Butanol Fraction and Rutin from Tartary Buckwheat Improve Cognition and Memory in an <i>In Vivo</i> Model of Amyloid- <i>β</i> -Induced Alzheimer's Disease.
  69. Peng-Xin Xu,Shao-Wei Wang,Xiao-Lin Yu,Ya-Jing Su,Teng Wang,Wei-Wei Zhou,He Zhang,Yu-Jiong Wang,Rui-Tian Liu (2014). Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
  70. Sahar Moghbelinejad,Marjan Nassiri-Asl,Taghi Naserpour Farivar,Esmail Abbasi,Mehdi Sheikhi,Mina Taghiloo,Farzaneh Farsad,Amir Samimi,Farid Hajiali (2014). Rutin activates the MAPK pathway and BDNF gene expression on beta-amyloid induced neurotoxicity in rats.
  71. Mirjana Colovic,Danijela Krstic,Tamara Lazarevic-Pasti,Aleksandra Bondzic,Vesna Vasic (2013). Acetylcholinesterase Inhibitors: Pharmacology and Toxicology.
  72. Fátima Abdalla,Roberta Schmatz,Andréia Cardoso,Fabiano Carvalho,Jucimara Baldissarelli,Juliane De Oliveira,Michelle Rosa,Matheus Gonçalves Nunes,Maribel Rubin,Ivana Da Cruz,Fernanda Barbisan,Valderi Dressler,Luciane Pereira,Maria Schetinger,Vera Morsch,Jamile Gonçalves,Cinthia Mazzanti (2014). Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: Possible involvement of the acetylcholinesterase and Na+,K+-ATPase activities.
  73. Jucimara Baldissarelli,Adriana Santi,Roberta Schmatz,Fátima Abdalla,Andréia Cardoso,Caroline Martins,Glaecir Dias,Nicéia Calgaroto,Luana Pelinson,Karine Reichert,Vania Loro,Vera Morsch,Maria Schetinger (2016). Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.
  74. M Islam,A Zaman,I Jahan,R Chakravorty,S Chakraborty (2013). In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.
  75. Zul Kamal,Farhat Ullah,Muhammad Ayaz,Abdul Sadiq,Sajjad Ahmad,Anwar Zeb,Abid Hussain,Muhammad Imran (2015). Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological disorders.
  76. Jcr Vellosa,L Regasini,N Khalil (2011). Antioxidant and cytotoxic studies for kaempferol, quercetin and isoquercitrin.
  77. G Orfali,C Di,A Duarte,V Bonadio (2016). Review of anticancer mechanisms of isoquercitin.
  78. T-B Ahn,B Jeon (2015). The role of quercetin on the survival of neuron-like PC12 cells and the expression of alpha-synuclein.
  79. Min Zhu,Shubo Han,Anthony Fink (2013). Oxidized quercetin inhibits α-synuclein fibrillization.
  80. S Karuppagounder,S Madathil,M Pandey,R Haobam,U Rajamma,K Mohanakumar (2013). Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats.
  81. Denny Joseph,K,Muralidhara (2015). Combined oral supplementation of fish oil and quercetin enhances neuroprotection in a chronic rotenone rat model: relevance to Parkinson's disease.
  82. Julie Bournival,Patrik Quessy,Maria-Grazia Martinoli (2009). Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons.
  83. Z Zhang,Lcv Cheang,M Wang,Sm-Y Lee (2011). Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and proinflammation gene expression in PC12 cells and in zebrafish.
  84. Julie Bournival,Marilyn Plouffe,Justine Renaud,Cindy Provencher,Maria-Grazia Martinoli (2012). Quercetin and Sesamin Protect Dopaminergic Cells from MPP<sup>+</sup>-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System.
  85. Nagaraja Haleagrahara,Cheng Siew,Kumar Ponnusamy (2013). Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.
  86. Kasthuri Magalingam,Ammu Radhakrishnan,Nagaraja Haleagrahara (2014). Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA) - induced toxicity in PC12 cells.
  87. Kasthuri Magalingam,Ammu Radhakrishnan,Premdass Ramdas,Nagaraja Haleagrahara (2015). Quercetin Glycosides Induced Neuroprotection by Changes in the Gene Expression in a Cellular Model of Parkinson’s Disease.
  88. Kasthuri Magalingam,Ammu Radhakrishnan,Nagaraja Haleagrahara (2016). Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells.
  89. Christopher Ross,Sarah Tabrizi (2011). Huntington's disease: from molecular pathogenesis to clinical treatment.
  90. Mju Novak,S Tabrizi (2010). Huntington's disease.
  91. Gillian Bates,Ray Dorsey,James Gusella,Michael Hayden,Chris Kay,Blair Leavitt,Martha Nance,Christopher Ross,Rachael Scahill,Ronald Wetzel,Edward Wild,Sarah Tabrizi (2015). Huntington disease.
  92. R Sandhir,A Mehrotra (2013). Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease.
  93. Dilpesh Jain,Arti Gangshettiwar (2014). Combination of lycopene, quercetin and poloxamer188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntingtons disease in rats.
  94. J Chakraborty,R Singh,D Dutta,A Naskar,U Rajamma,K Mohanakumar (2014). Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Ana Carolina Duarte. 2017. \u201cLiterature Evidence and Arrive Assessment on Neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models\u201d. Global Journal of Medical Research - A: Neurology & Nervous System GJMR-A Volume 17 (GJMR Volume 17 Issue A1): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-A Classification: NLMC Code: WL 140
Version of record

v1.2

Issue date

November 22, 2017

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 3346
Total Downloads: 1596
2026 Trends
Related Research

Published Article

This paper was based on a literature search of PubMed and Scielo databases using the keywords “Flavonoids, Neuroprotection, Quercetin, Rutin, Isoquercitrin, Alzheimer, Parkinson, Huntington” and combinations of all the words. We collected relevant publications, during the period of 2000 to 2016, emphasizing in vivo and in vitro studies with neurological assessment of flavonol’s potentials, as well as classifying studies according to evidence levels, in order to elucidate evidence-based literature and its application on clinical research. In addition, we highlight the importance of flavonols in modern research fields, indicating their neuroprotective potential and use thereof as preventive and therapeutic treatment of numerous neurodegenerative disease. Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, represent worldwide a major health problem with great financial impact. They are multifactorial diseases, hallmarked by similar pathogenesis that covers conditions such as oxidative stress, formation of free radicals, abnormal protein dynamics (degradation and aggregation), mitochondrial dysfunction, lipid peroxidation and cellular death or senescence. Flavonols are polyphenolic compounds, widely distributed in the plant kingdom and found in high concentrations in vegetables, fruits and teas. Their neuroprotective effects are mainly related to their antioxidant, anti-proliferative and antiinflammatory properties. It was this paper’s intention to contribute with an evidence analysis of recent studies approaching neuroprotective effects of flavonols and the potential to conduct human clinical studies.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Literature Evidence and Arrive Assessment on Neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models

Ana Carolina Bombardi Duarte
Ana Carolina Bombardi Duarte
Maycon Giovani Santanai
Maycon Giovani Santanai
Gulhermedi Camilo Orfalii
Gulhermedi Camilo Orfalii
Carlos Tadeu Parisi de Oliveira
Carlos Tadeu Parisi de Oliveira
Denise GonAalves Priolli
Denise GonAalves Priolli

Research Journals